http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201902686-T4
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
filingDate | 2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09df9c3011f4014120ba3aef3cf9e923 |
publicationDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TR-201902686-T4 |
titleOfInvention | Aurora A kinase inhibitor. |
abstract | The present invention includes (2S, 4S) -1 - [(3-chloro-2-fluoro-phenyl) methyl] -4 - [[3-fluoro-6 - [(5-methyl-1H-pyrazol-3-yl) amino ] -2-pyridyl] methyl] -2-methyl-piperidine-4-carboxylic acid (Formula 1) and (2R, 4R) -1 - [(3-chloro-2-fluoro-phenyl) methyl] -4- [[3-fluoro-6- [(5-methyl-1H-pyrazol-3-yl) amino] -2-pyridyl] methyl] -2-methyl-piperidine-4-carboxylic acid (Formula 2) or their pharmaceutical It provides an aminopyridine compound, selected from the group consisting of an acceptable salt thereof, that inhibits Aurora A and thus may be useful in cancer therapy. |
priorityDate | 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.